撤回“纳米结构脂质载体递送索拉非尼以增强阿霉素诱导的免疫疗法用于有效食管癌治疗”
Retraction of "Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy".
作者信息
Wang Jia-Yang, Song Ya-Qi, Peng Jing, Luo Hong-Lei
出版信息
ACS Omega. 2021 Jul 19;6(29):19342. doi: 10.1021/acsomega.1c02888. eCollection 2021 Jul 27.
Abstract
[This retracts the article DOI: 10.1021/acsomega.0c02072.].
摘要
[本文撤回文章DOI: 10.1021/acsomega.0c02072。]
相似文献
1
Retraction of "Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy".撤回“纳米结构脂质载体递送索拉非尼以增强阿霉素诱导的免疫疗法用于有效食管癌治疗”
ACS Omega. 2021 Jul 19;6(29):19342. doi: 10.1021/acsomega.1c02888. eCollection 2021 Jul 27.
2
Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy.纳米结构脂质载体递送索拉非尼以增强阿霉素诱导的免疫疗法用于有效的食管癌治疗。
ACS Omega. 2020 Sep 2;5(36):22840-22846. doi: 10.1021/acsomega.0c02072. eCollection 2020 Sep 15.
3
A cell membrane vehicle co-delivering sorafenib and doxorubicin remodel the tumor microenvironment and enhance immunotherapy by inducing immunogenic cell death in lung cancer cells.细胞膜载体共递送索拉非尼和多柔比星重塑肿瘤微环境，并通过诱导肺癌细胞发生免疫原性细胞死亡增强免疫治疗。
J Mater Chem B. 2020 Sep 14;8(34):7755-7765. doi: 10.1039/d0tb01052a. Epub 2020 Jul 31.
4
Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers [Retraction].载有米替福新的纳米结构脂质载体的制备、药代动力学及抗肿瘤潜力[撤回]
Int J Nanomedicine. 2023 Mar 1;18:1107-1108. doi: 10.2147/IJN.S409956. eCollection 2023.
5
Optimized Nanostructured Lipid Carriers Integrated into in situ Nasal Gel for Enhancing Brain Delivery of Flibanserin [Retraction].优化的纳米结构脂质载体整合到原位鼻腔凝胶中以增强氟班色林的脑递送[撤回]
Int J Nanomedicine. 2023 Apr 28;18:2253-2254. doi: 10.2147/IJN.S419019. eCollection 2023.
6
Retraction of "Red Blood Cell Membrane-Coated Silica Nanoparticles Codelivering DOX and ICG for Effective Lung Cancer Therapy".撤回《红细胞膜包被的二氧化硅纳米颗粒共递送阿霉素和吲哚菁绿用于肺癌有效治疗》
ACS Omega. 2021 Jul 20;6(30):20088. doi: 10.1021/acsomega.1c02886. eCollection 2021 Aug 3.
7
Retraction of "Roflumilast Ameliorates Isoflurane-Induced Inflammation in Astrocytes the CREB/BDNF Signaling Pathway".《罗氟司特改善异氟烷诱导的星形胶质细胞炎症及 CREB/BDNF 信号通路》撤稿声明
ACS Omega. 2021 Aug 12;6(33):21842. doi: 10.1021/acsomega.1c03897. eCollection 2021 Aug 24.
8
Retraction of "Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis".撤回“罗格列酮（一种PPAR-γ激动剂）对二乙基亚硝胺诱导的肺癌发生的抗癌作用”
ACS Omega. 2021 Nov 19;6(48):33239. doi: 10.1021/acsomega.1c06159. eCollection 2021 Dec 7.
9
Retraction of "Icariin Alleviates Bisphenol A Induced Disruption of Intestinal Epithelial Barrier by Maintaining Redox Homeostasis and ".《淫羊藿苷通过维持氧化还原稳态减轻双酚A诱导的肠道上皮屏障破坏》撤稿声明
ACS Omega. 2021 Jul 19;6(30):20090. doi: 10.1021/acsomega.1c03182. eCollection 2021 Aug 3.
10
Antileukemic Effect of Zerumbone-Loaded Nanostructured Lipid Carrier in WEHI-3B Cell-Induced Murine Leukemia Model [Retraction].零陵香酮负载纳米结构脂质载体在WEHI-3B细胞诱导的小鼠白血病模型中的抗白血病作用[撤回]
Int J Nanomedicine. 2022 Jun 7;17:2557-2558. doi: 10.2147/IJN.S377150. eCollection 2022.
Zotero 插件